Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
November 8, 2023 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 16, 2023 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
May 16, 2023 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
May 25, 2023 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
May 25, 2023 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
February 1, 2024 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
February 1, 2024 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
February 27, 2024 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
February 27, 2024 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
February 27, 2024 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us